SELENIUM AND LUNG CANCER RISK IN ASBESTOS WORKERS
SELENIUM AND LUNG CANCER RISK IN ASBESTOS WORKERS
批准号:
6647696
负责人:
EVA B GOTTSCHALL
金额:
$12.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-21 至 2005-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Applicant's Description) Lung cancer accounts for more cancer
deaths in the United States than breast, prostate and colorectal cancer
combined. Efforts to improve early detection, develop successful screening
programs and find effective chemopreventive agents are desirable. Selenium
has shown promise as a cancer chemopreventive agent in animal and human
studies. A putative mechanism of selenium's anticarcinogenic activity is its
integral part in cellular antioxidant systems. Asbestos-exposed workers have
a well established increased incidence of lung cancer, and asbestos
carcinogenesis is thought to involve activated oxygen species. In a
cross-sectional study of asbestos-exposed workers, a large number of
individuals were found to have moderate sputum atypia (28 percent), a marker
of lung cancer risk. The major hypothesis of this proposal is that
asbestos-exposed workers treated with oral selenium-rich yeast (200gg/day)
will show significant improvement in intermediate end-point biomarkers of lung
cancer risk compared to placebo; and furthermore, changes in markers of lung
cancer will be accompanied by decreases in markers of oxidative cellular
damage. The study design is a randomized, placebo-controlled, double blind
trial of asbestos-exposed construction trades workers using high selenium
yeast supplementation. Markers of lung cancer risk to be examined include
sputum cytologic atypia, endobronchial metaplasia/dysplasia, and nuclear
morphometry of sputum and endobronchial biopsy specimens. The mechanism of
action of selenium will be investigated using markers of oxidative cellular
damage, including 8-hydroxydeoxyguanosine (a marker of DNA damage),
malondialdehyde (a marker of lipid peroxidation), and 8-iso-prostaglandine F2,
(a marker of lipid peroxidation), before and after the intervention. The
proposed study will assess whether selenium is effective in reversing
premalignant lesions indicative of increased lung cancer risk and elucidate
potential mechanisms of action of selenium. As such, this study will provide
a critical foundation to further establish selenium as a potential
chemopreventive agent for human lung cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Selenium and Lung Cancer Risk in Asbestos Workers
-
批准号:6982112
-
项目类别:
-
资助金额:$1.87万
-
财政年份:2004
-
负责人:EVA B GOTTSCHALL
-
依托单位:
SELENIUM AND LUNG CANCER RISK IN ASBESTOS WORKERS
-
批准号:6522521
-
项目类别:
-
资助金额:$6.17万
-
财政年份:2000
-
负责人:EVA B GOTTSCHALL
-
依托单位:
SELENIUM AND LUNG CANCER RISK IN ASBESTOS WORKERS
-
批准号:6845692
-
项目类别:
-
资助金额:$6.17万
-
财政年份:2000
-
负责人:EVA B GOTTSCHALL
-
依托单位:
SELENIUM AND LUNG CANCER RISK IN ASBESTOS WORKERS
-
批准号:6699410
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2000
-
负责人:EVA B GOTTSCHALL
-
依托单位:
SELENIUM AND LUNG CANCER RISK IN ASBESTOS WORKERS
-
批准号:6377642
-
项目类别:
-
资助金额:$12.07万
-
财政年份:2000
-
负责人:EVA B GOTTSCHALL
-
依托单位:
SELENIUM AND LUNG CANCER RISK IN ASBESTOS WORKERS
-
批准号:6192912
-
项目类别:
-
资助金额:$11.8万
-
财政年份:2000
-
负责人:EVA B GOTTSCHALL
-
依托单位:
海外基金